People who had biennial fecal occult blood test screenings for colorectal cancer had a 16% lower risk of dying from colorectal cancer and a 2% reduced risk of all-cause mortality, compared with those who had usual care, according to a study in Clinical Gastroenterology and Hepatology. The risk reduction was greater for men than for women.
Sign up for SNMMI SmartBrief
Nuclear medicine and molecular imaging news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.